Social development, better living conditions and medical advances lead to the fact that more people have the opportunity to live longer than in the past. The aging population is a characteristic feature of demographic trends in developed countries. This trend is closely linked with the issue of increasing number of diseases in old age and increasing government expenditure on health and social care. The most frequently mentioned diseases in old age include dementia. The cause may lie in all kinds of diseases, the most common are Alzheimer's disease and cerebrovascular disease. Now the care of current 35 million patients with dementia costs over $ 600 billion per year, it is approximately one percent of global Gross Domestic Product. This review discusses the recent issues and questions in the area of social and economic aspects of Alzheimer's disease. It focuses in detail on the national strategies in the approach to Alzheimer's disease, the anticipated problems concerning the insufficient number of social workers and necessary expenses of state budgets in the future. The situation in the area of health insurance companies' expenditures is illustrated in the context of the analysis of long-term care systems, in the chosen countries within the European Union.

Faculty of Informatics and Management University of Hradec Kralove Hradec Kralove Czech Republic;

Citace poskytuje Crossref.org

Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system

Multi-spectroscopic monitoring of molecular interactions between an amino acid-functionalized ionic liquid and potential anti-Alzheimer's drugs

Caregivers' Experience of Caring for a Family Member with Alzheimer's Disease: A Content Analysis of Longitudinal Social Media Communication

Synthesis of New Quinoline-Piperonal Hybrids as Potential Drugs against Alzheimer's Disease

Predictions of Alzheimer's disease treatment and care costs in European countries

The direct costs of multiple sclerosis-study in the Czech Republic

Profiling donepezil template into multipotent hybrids with antioxidant properties

Technological Solutions for Older People with Alzheimer's Disease: Review

Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment

Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy

Cognitive decline in normal aging and its prevention: a review on non-pharmacological lifestyle strategies

The economic burden of the care and treatment for people with Alzheimer's disease: the outlook for the Czech Republic

Treatment cost of narcolepsy with cataplexy in Central Europe

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model

7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment